OTC Markets OTCPK - Delayed Quote USD
Nexien BioPharma, Inc. (NXEN)
0.0100
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
119.9690
155.6630
282.6080
453.7280
1,843.7670
Operating Income
-119.9690
-155.6630
-282.6080
-453.7280
-1,843.7670
Net Non Operating Interest Income Expense
-91.1840
-83.4500
-79.2940
-62.3650
-16.1750
Other Income Expense
-35
--
--
-110.2640
--
Pretax Income
-211.1530
-239.1130
-361.9020
-626.3570
-1,859.9420
Net Income Common Stockholders
-211.1530
-239.1130
-361.9020
-626.3570
-1,859.9420
Diluted NI Available to Com Stockholders
-211.1530
-239.1130
-361.9020
-626.3570
-1,859.9420
Basic EPS
-0.00
-0.00
-0.01
-0.01
-0.03
Diluted EPS
-0.00
-0.00
-0.01
-0.01
-0.03
Basic Average Shares
69,082.6380
66,193.8400
62,333.3220
57,860.1080
55,399.6430
Diluted Average Shares
70,772.1960
66,193.8400
62,333.3220
57,860.1080
55,399.6430
Total Expenses
119.9690
155.6630
282.6080
453.7280
1,843.7670
Net Income from Continuing & Discontinued Operation
-211.1530
-239.1130
-361.9020
-626.3570
-1,859.9420
Normalized Income
-211.1530
-239.1130
-361.9020
-516.0930
-1,859.9420
Interest Expense
91.1840
83.4500
79.2940
62.3650
16.1750
Net Interest Income
-91.1840
-83.4500
-79.2940
-62.3650
-16.1750
EBIT
-119.9690
-155.6630
-282.6080
-563.9920
-1,843.7670
EBITDA
-119.9690
-155.6630
-282.6080
-563.9920
-1,843.7670
Net Income from Continuing Operation Net Minority Interest
-211.1530
-239.1130
-361.9020
-626.3570
-1,859.9420
Total Unusual Items Excluding Goodwill
--
--
--
-110.2640
0
Total Unusual Items
--
--
--
-110.2640
0
Normalized EBITDA
-119.9690
-155.6630
-282.6080
-453.7280
-1,843.7670
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 11/29/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade